Frank L Meyskens

Title(s)Recall Faculty, Medicine
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(714) 456-5153
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    The 19th Annual Meeting of the Pan American Society for Pigment Cell Research Conference
    NIH/NIAMS R13AR068914Aug 1, 2015 - Jul 31, 2016
    Role: Principal Investigator
    SWOG NCORP Research Base
    NIH/NCI UG1CA189974Aug 1, 2014 - Jul 31, 2025
    Role: Co-Principal Investigator
    7th International Conference on Clinical Cancer Prevention 2012 with Consensus Co
    NIH/NCI R13CA171707Mar 1, 2013 - Feb 28, 2014
    Role: Principal Investigator
    PanAmerican Society for Pigment Cell Research (PASPCR)
    NIH/NCI R13CA110471Jul 16, 2004 - Jul 15, 2005
    Role: Principal Investigator
    Phase III Colon Cancer Prevention Trial
    NIH/NCI R01CA088078Sep 30, 2002 - Aug 31, 2010
    Role: Principal Investigator
    CHEMOPREVENTION OF FAMILIAL PROSTATE CANCER
    NIH/NCI U19CA081886Sep 30, 1999 - Sep 30, 2007
    Role: Principal Investigator
    PHASE II CLINICAL TRIAL OF TOPICAL POLYPHENON E
    NIH/NCI N01CN085182Sep 30, 1998
    Role: Principal Investigator
    Chemoprevention of Oral Cancer with BBIC
    NIH/NCI U01CA072294Mar 14, 1997 - Feb 28, 2003
    Role: Principal Investigator
    Colon Cancer Prevention Program Project Grant
    NIH/NCI P01CA041108Mar 1, 1997 - Sep 13, 2000
    Role: Co-Principal Investigator
    PHASE II CLINICAL TRIAL OF DFMO AND NSAIDIN COLON - WORKSTATEMENT 45 -261075019
    NIH/NCI N01CN075019Feb 15, 1997
    Role: Co-Principal Investigator
    Chemoprevention of Skin Cancer Program Project
    NIH/NCI P01CA027502Dec 1, 1996 - Nov 30, 1997
    Role: Co-Principal Investigator
    SIXTEEN INTERNATIONAL PIGMENT CELL CONFERENCE
    NIH/NCI R13CA072887Sep 30, 1996 - Sep 29, 1997
    Role: Principal Investigator
    CLIN CTR CLINICAL TRIAL/OBSERVATIONAL STUDY OF WHI
    NIH/WHI N01WH042107Sep 30, 1994 - Sep 14, 2005
    Role: Co-Principal Investigator
    Cancer Center Support Grant
    NIH P30CA062203Aug 15, 1994 - Jan 31, 2021
    Role: Co-Principal Investigator
    SOUTHWEST ONCOLOGY GROUP
    NIH/NCI U10CA058723Aug 1, 1993 - Dec 31, 1997
    Role: Principal Investigator
    POLYAMINE DEPLETION AND CHEMOPREVENTION OF COLON CANCER
    NIH/NCI R01CA059024May 1, 1993 - Feb 28, 1998
    Role: Principal Investigator
    CARET--THE CAROTENE AND RETINOL EFFICACY TRIAL
    NIH/NCI U01CA052596Aug 22, 1991 - Jun 30, 1999
    Role: Principal Investigator
    CHEMOPREVENTION EFFICACY TRIAL OF BETA CAROTENE/RETINOL
    NIH/NCI R01CA052596Aug 22, 1991 - Jun 30, 1995
    Role: Principal Investigator
    CHEMOPREVENTION OF HUMAN MELANOMA
    NIH/NCI U01CA051610Jun 1, 1989 - May 31, 1992
    Role: Principal Investigator
    CHEMOPREVENTION OF HUMAN CANCER
    NIH/NCI R13CA046424Jan 1, 1988 - Dec 31, 1988
    Role: Principal Investigator
    MODULATION AND MEDIATION OF CANCER BY VITAMINS
    NIH/NCI R13CA038506Feb 6, 1985 - Feb 5, 1986
    Role: Principal Investigator
    SWOG Community Clinical Oncology Program Research Base
    NIH/NCI U10CA037429Sep 30, 1983 - May 31, 2015
    Role: Co-Principal Investigator
    Phase I and II Clinical Trials of Agents for Cancer Prevention
    NIH/NCI N01CN35160Sep 29, 2009
    Role: Co-Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Recent Advances in Clinical Research for Skin Cancer Chemoprevention. Cancers (Basel). 2023 Jul 27; 15(15). Tow R, Hanoun S, Andresen B, Shahid A, Wang J, Kelly KM, Meyskens FL, Huang Y. PMID: 37568635; PMCID: PMC10417305.
      View in: PubMed   Mentions:
    2. Transfersome Encapsulated with the R-carvedilol Enantiomer for Skin Cancer Chemoprevention. Nanomaterials (Basel). 2023 Mar 03; 13(5). Shamim MA, Shahid A, Sardar PK, Yeung S, Reyes J, Kim J, Parsa C, Orlando R, Wang J, Kelly KM, Meyskens FL, Andresen BT, Huang Y. PMID: 36903807; PMCID: PMC10005314.
      View in: PubMed   Mentions: 4  
    3. Topical carvedilol delivery prevents UV-induced skin cancer with negligible systemic absorption. Int J Pharm. 2022 Jan 05; 611:121302. Abdullah Shamim M, Yeung S, Shahid A, Chen M, Wang J, Desai P, Parsa C, Orlando R, Meyskens FL, Kelly KM, Andresen BT, Huang Y. PMID: 34793935; PMCID: PMC8692451.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    4. Topical Delivery of Carvedilol Loaded Nano-Transfersomes for Skin Cancer Chemoprevention. Pharmaceutics. 2020 Nov 27; 12(12). Chen M, Shamim MA, Shahid A, Yeung S, Andresen BT, Wang J, Nekkanti V, Meyskens FL, Kelly KM, Huang Y. PMID: 33260886; PMCID: PMC7761092.
      View in: PubMed   Mentions: 18  
    5. Abscopal Outcomes: Reflections on Distant Effects. Pract Radiat Oncol. 2019 Sep - Oct; 9(5):294. Meyskens FL. PMID: 31103714.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials. Cancer. 2019 01 01; 125(1):18-44. Jeter JM, Bowles TL, Curiel-Lewandrowski C, Swetter SM, Filipp FV, Abdel-Malek ZA, Geskin LJ, Brewer JD, Arbiser JL, Gershenwald JE, Chu EY, Kirkwood JM, Box NF, Funchain P, Fisher DE, Kendra KL, Marghoob AA, Chen SC, Ming ME, Albertini MR, Vetto JT, Margolin KA, Pagoto SL, Hay JL, Grossman D, Ellis DL, Kashani-Sabet M, Mangold AR, Markovic SN, Meyskens FL, Nelson KC, Powers JG, Robinson JK, Sahni D, Sekulic A, Sondak VK, Wei ML, Zager JS, Dellavalle RP, Thompson JA, Weinstock MA, Leachman SA, Cassidy PB. PMID: 30281145; PMCID: PMC6860362.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    7. 12-Hydroxyeicosatetraenoic acid levels are increased in actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2018 Dec; 79(6):1152-1153. Laquer V, Dellinger RW, Mannering I, Garcia AG, Abraham V, Pavlis J, Liu-Smith F, De Feraudy S, Meyskens FL, Kelly KM. PMID: 29902547; PMCID: PMC6260832.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Systems biology analysis of mitogen activated protein kinase inhibitor resistance in malignant melanoma. BMC Syst Biol. 2018 04 04; 12(1):33. Zecena H, Tveit D, Wang Z, Farhat A, Panchal P, Liu J, Singh SJ, Sanghera A, Bainiwal A, Teo SY, Meyskens FL, Liu-Smith F, Filipp FV. PMID: 29615030; PMCID: PMC5883534.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    9. Topically Applied Carvedilol Attenuates Solar Ultraviolet Radiation Induced Skin Carcinogenesis. Cancer Prev Res (Phila). 2017 Oct; 10(10):598-606. Huang KM, Liang S, Yeung S, Oiyemhonlan E, Cleveland KH, Parsa C, Orlando R, Meyskens FL, Andresen BT, Huang Y. PMID: 28912118.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    10. Redox-Redux and NADPH Oxidase (NOX): Even More Complicated than We Thought it Might Be. J Invest Dermatol. 2017 Jun; 137(6):1208-1210. Meyskens FL, Liu-Smith F. PMID: 28532757.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    11. What to Do With the Participants/Patients in Phase III Clinical Cancer Trials That Have Been Stopped by the FDA. J Natl Cancer Inst. 2016 12; 108(12). Meyskens FL. PMID: 27986883.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Measuring Redox Status of Melanoma Cells. Methods Mol Biol. 2016 Apr 10. Liu-Smith F, Krasieva TB, Liu J, Liu J, Meyskens FL. PMID: 27062599; PMCID: PMC5878701.
      View in: PubMed   Mentions: 4     Fields:    
    13. Detection of Total UDP-Glucuronosyltransferase (UGT) Activity in Melanoma Cells. Methods Mol Biol. 2016 Jan 20. Dellinger RW, Meyskens FL. PMID: 26786882.
      View in: PubMed   Mentions:    Fields:    
    14. Risk Factor Models and Personalized Health: Opportunities and Challenges for Asymptomatic Individuals. Cancer Prev Res (Phila). 2016 Jan; 9(1):11-2. Meyskens FL. PMID: 26701663.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Cancer Prevention: Obstacles, Challenges and the Road Ahead. J Natl Cancer Inst. 2016 Feb; 108(2). Meyskens FL, Mukhtar H, Rock CL, Cuzick J, Kensler TW, Yang CS, Ramsey SD, Lippman SM, Alberts DS. PMID: 26547931; PMCID: PMC4907357.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansAnimalsPHPublic Health
    16. Barriers to a Career Focus in Cancer Prevention: A Report and Initial Recommendations From the American Society of Clinical Oncology Cancer Prevention Workforce Pipeline Work Group. J Clin Oncol. 2016 Jan 10; 34(2):186-93. Fabian CJ, Meyskens FL, Bajorin DF, George TJ, Jeter JM, Khan S, Tyne CA, William WN. PMID: 26527778; PMCID: PMC5070551.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Methods to Standardize a Multicenter Acupuncture Trial Protocol to Reduce Aromatase Inhibitor-related Joint Symptoms in Breast Cancer Patients. J Acupunct Meridian Stud. 2015 Jun; 8(3):152-8. Greenlee H, Crew KD, Capodice J, Awad D, Jeffres A, Unger JM, Lew DL, Hansen LK, Meyskens FL, Wade JL, Hershman DL. PMID: 26100070; PMCID: PMC4705910.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    18. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med. 2015 03 05; 372(10):923-32. Moore HC, Unger JM, Phillips KA, Boyle F, Hitre E, Porter D, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS, Partridge AH, Dakhil SR, Garcia AA, Gralow J, Lombard JM, Forbes JF, Martino S, Barlow WE, Fabian CJ, Minasian L, Meyskens FL, Gelber RD, Hortobagyi GN, Albain KS, POEMS/S0230 Investigators. PMID: 25738668; PMCID: PMC4405231.
      View in: PubMed   Mentions: 151     Fields:    Translation:HumansCTClinical Trials
    19. Amyloids, melanins and oxidative stress in melanomagenesis. Exp Dermatol. 2015 Mar; 24(3):171-4. Liu-Smith F, Poe C, Farmer PJ, Meyskens FL. PMID: 25271672; PMCID: PMC4507564.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    20. Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Prev Res (Phila). 2014 Sep; 7(9):886-95. Albanes D, Till C, Klein EA, Goodman PJ, Mondul AM, Weinstein SJ, Taylor PR, Parnes HL, Gaziano JM, Song X, Fleshner NE, Brown PH, Meyskens FL, Thompson IM. PMID: 24961880; PMCID: PMC4408535.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    21. Continuing to illuminate the mechanisms underlying UV-mediated melanomagenesis. J Photochem Photobiol B. 2014 Sep 05; 138:317-23. Dellinger RW, Liu-Smith F, Meyskens FL. PMID: 25022944; PMCID: PMC4230791.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    22. Updates of reactive oxygen species in melanoma etiology and progression. Arch Biochem Biophys. 2014 Dec 01; 563:51-5. Liu-Smith F, Dellinger R, Meyskens FL. PMID: 24780245; PMCID: PMC4209333.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansAnimalsCells
    23. Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev. 2014 Aug; 23(8):1494-504. Kristal AR, Till C, Song X, Tangen CM, Goodman PJ, Neuhauser ML, Schenk JM, Thompson IM, Meyskens FL, Goodman GE, Minasian LM, Parnes HL, Klein EA. PMID: 24732629; PMCID: PMC4119495.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    24. A randomized, double-blind, placebo-controlled phase II clinical trial of lovastatin for various endpoints of melanoma pathobiology. Cancer Prev Res (Phila). 2014 May; 7(5):496-504. Linden KG, Leachman SA, Zager JS, Jakowatz JG, Viner JL, McLaren CE, Barr RJ, Carpenter PM, Chen WP, Elmets CA, Tangrea JA, Lim SJ, Cochran AJ, Meyskens FL. PMID: 24614012; PMCID: PMC4208700.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    25. Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk. J Natl Cancer Inst. 2014 Mar; 106(3):djt456. Kristal AR, Darke AK, Morris JS, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL, Goodman GE, Minasian LM, Parnes HL, Lippman SM, Klein EA. PMID: 24563519; PMCID: PMC3975165.
      View in: PubMed   Mentions: 103     Fields:    Translation:Humans
    26. Chemoprevention of prostate cancer with the polyamine synthesis inhibitor difluoromethylornithine. Recent Results Cancer Res. 2014; 202:115-20. Meyskens FL, Simoneau AR, Gerner EW. PMID: 24531785.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCellsCTClinical Trials
    27. Differences in the glucuronidation of resveratrol and pterostilbene: altered enzyme specificity and potential gender differences. Drug Metab Pharmacokinet. 2014; 29(2):112-9. Dellinger RW, Garcia AM, Meyskens FL. PMID: 23965644; PMCID: PMC4487664.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    28. Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst. 2013 Aug 07; 105(15):1132-41. Brasky TM, Darke AK, Song X, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL, Goodman GE, Minasian LM, Parnes HL, Klein EA, Kristal AR. PMID: 23843441; PMCID: PMC3735464.
      View in: PubMed   Mentions: 98     Fields:    Translation:Humans
    29. Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial. Cancer Prev Res (Phila). 2013 May; 6(5):410-8. Armstrong WB, Taylor TH, Kennedy AR, Melrose RJ, Messadi DV, Gu M, Le AD, Perloff M, Civantos F, Goodwin WJ, Wirth LJ, Kerr AR, Meyskens FL. PMID: 23639862; PMCID: PMC3730525.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    30. The pan-Aurora kinase inhibitor, PHA-739358, induces apoptosis and inhibits migration in melanoma cell lines. Melanoma Res. 2013 Apr; 23(2):102-13. Xie L, Meyskens FL. PMID: 23344158; PMCID: PMC4077197.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    31. A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important. Pigment Cell Melanoma Res. 2013 Jan; 26(1):128-35. Liu F, Bessonova L, Taylor TH, Ziogas A, Meyskens FL, Anton-Culver H. PMID: 23095171; PMCID: PMC4028153.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    32. Anti-cancer drugs elicit re-expression of UDP-glucuronosyltransferases in melanoma cells. PLoS One. 2012; 7(10):e47696. Dellinger RW, Matundan HH, Ahmed AS, Duong PH, Meyskens FL. PMID: 23110092; PMCID: PMC3478267.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    33. NADPH oxidase 1 overexpression enhances invasion via matrix metalloproteinase-2 and epithelial-mesenchymal transition in melanoma cells. J Invest Dermatol. 2012 Aug; 132(8):2033-41. Liu F, Gomez Garcia AM, Meyskens FL. PMID: 22513785.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    34. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011 Oct 12; 306(14):1549-56. Klein EA, Thompson IM, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL, Baker LH. PMID: 21990298; PMCID: PMC4169010.
      View in: PubMed   Mentions: 670     Fields:    Translation:Humans
    35. Colorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions. Clin Colorectal Cancer. 2011 Dec; 10(4):310-6. Chu DZ, Hussey MA, Alberts DS, Meyskens FL, Fenoglio-Preiser CM, Rivkin SE, Mills GM, Giguere JK, Blanke CD, Goodman GE. PMID: 21782524; PMCID: PMC4286321.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    36. Back to the future: mechanism-based, mutation-specific combination chemoprevention with a synthetic lethality approach. Cancer Prev Res (Phila). 2011 May; 4(5):628-32. Meyskens FL, Gerner EW. PMID: 21543341; PMCID: PMC3574813.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    37. Therapeutic prevention of colorectal carcinogenesis. J Carcinog. 2011; 10:13. Meyskens FL. PMID: 21712960; PMCID: PMC3122104.
      View in: PubMed   Mentions: 1  
    38. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila). 2011 Mar; 4(3):354-64. Carroll RE, Benya RV, Turgeon DK, Vareed S, Neuman M, Rodriguez L, Kakarala M, Carpenter PM, McLaren C, Meyskens FL, Brenner DE. PMID: 21372035; PMCID: PMC4136551.
      View in: PubMed   Mentions: 190     Fields:    Translation:HumansCTClinical Trials
    39. Regulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinic. Cancer Prev Res (Phila). 2011 Mar; 4(3):311-23. Meyskens FL, Curt GA, Brenner DE, Gordon G, Herberman RB, Finn O, Kelloff GJ, Khleif SN, Sigman CC, Szabo E, C-Change Chemoprevention Clinical Trials and Biomarkers Subcommittee. PMID: 21372031; PMCID: PMC3059243.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    40. Thinking about the role (largely ignored) of heavy metals in cancer prevention: hexavalent chromium and melanoma as a case in point. Recent Results Cancer Res. 2011; 188:65-74. Meyskens FL, Yang S. PMID: 21253789.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    41. Chemoprevention, risk reduction, therapeutic prevention, or preventive therapy? J Natl Cancer Inst. 2010 Dec 15; 102(24):1815-7. Meyskens FL, McLaren CE. PMID: 21115881.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    42. Melanoma: is hair the root of the problem? Pigment Cell Melanoma Res. 2011 Feb; 24(1):110-8. Garcia AM, McLaren CE, Meyskens FL. PMID: 20880199; PMCID: PMC3768291.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    43. MiTF links Erk1/2 kinase and p21 CIP1/WAF1 activation after UVC radiation in normal human melanocytes and melanoma cells. Mol Cancer. 2010 Aug 11; 9:214. Liu F, Singh A, Yang Z, Garcia A, Kong Y, Meyskens FL. PMID: 20701798; PMCID: PMC2928201.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    44. Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008. Clin Cancer Res. 2009 Sep 15; 15(18):5663-70. Okunieff P, Kachnic LA, Constine LS, Fuller CD, Gaspar LE, Hayes DF, Hooks J, Ling C, Meyskens FL, Philip PA, Raben D, Smalley SR, Swanson GP, Teicher BA, Thomas CR, Vikram B, Zelefsky MJ, Baker LH. PMID: 19723641; PMCID: PMC2978526.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    45. Food extracts for chemoprevention: quo vadis? Cancer Prev Res (Phila). 2009 Jul; 2(7):608-10. Meyskens FL. PMID: 19584073.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammation. Clin Cancer Res. 2009 Feb 01; 15(3):758-61. Gerner EW, Meyskens FL. PMID: 19188144; PMCID: PMC2666541.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimals
    47. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009 Jan 07; 301(1):39-51. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL, Baker LH, Coltman CA. PMID: 19066370; PMCID: PMC3682779.
      View in: PubMed   Mentions: 798     Fields:    Translation:HumansCTClinical Trials
    48. Nitric oxide initiates progression of human melanoma via a feedback loop mediated by apurinic/apyrimidinic endonuclease-1/redox factor-1, which is inhibited by resveratrol. Mol Cancer Ther. 2008 Dec; 7(12):3751-60. Yang Z, Yang S, Misner BJ, Chiu R, Liu F, Meyskens FL. PMID: 19074850.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    49. Longitudinal assessment of air conduction audiograms in a phase III clinical trial of difluoromethylornithine and sulindac for prevention of sporadic colorectal adenomas. Cancer Prev Res (Phila). 2008 Dec; 1(7):514-21. McLaren CE, Fujikawa-Brooks S, Chen WP, Gillen DL, Pelot D, Gerner EW, Meyskens FL. PMID: 19139001; PMCID: PMC2702261.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    50. MiTF regulates cellular response to reactive oxygen species through transcriptional regulation of APE-1/Ref-1. J Invest Dermatol. 2009 Feb; 129(2):422-31. Liu F, Fu Y, Meyskens FL. PMID: 18971960; PMCID: PMC4321967.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    51. Common and distinct mechanisms of different redox-active carcinogens involved in the transformation of mouse JB6P+ cells. Mol Carcinog. 2008 Jul; 47(7):485-91. Yang S, Misner B, Chiu R, Meyskens FL. PMID: 18092320; PMCID: PMC4587534.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    52. Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res (Phila). 2008 Jun; 1(1):32-8. Meyskens FL, McLaren CE, Pelot D, Fujikawa-Brooks S, Carpenter PM, Hawk E, Kelloff G, Lawson MJ, Kidao J, McCracken J, Albers CG, Ahnen DJ, Turgeon DK, Goldschmid S, Lance P, Hagedorn CH, Gillen DL, Gerner EW. PMID: 18841250; PMCID: PMC2562024.
      View in: PubMed   Mentions: 262     Fields:    Translation:Humans
    53. Melanosomal damage in normal human melanocytes induced by UVB and metal uptake--a basis for the pro-oxidant state of melanoma. Photochem Photobiol. 2008 May-Jun; 84(3):556-64. Gidanian S, Mentelle M, Meyskens FL, Farmer PJ. PMID: 18331399; PMCID: PMC5746029.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    54. UV or not UV: metals are the answer. Cancer Epidemiol Biomarkers Prev. 2008 Feb; 17(2):268-70. Meyskens FL, Berwick M. PMID: 18268109.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    55. The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial. Cancer Epidemiol Biomarkers Prev. 2008 Feb; 17(2):292-9. Simoneau AR, Gerner EW, Nagle R, Ziogas A, Fujikawa-Brooks S, Yerushalmi H, Ahlering TE, Lieberman R, McLaren CE, Anton-Culver H, Meyskens FL. PMID: 18268112; PMCID: PMC2515594.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    56. End-of-Life care: guidelines for patient-centered communication. Am Fam Physician. 2008 Jan 15; 77(2):167-74. Ngo-Metzger Q, August KJ, Srinivasan M, Liao S, Meyskens FL. PMID: 18246886.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    57. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol. 2008 Jan 01; 26(1):66-75. Zell JA, Cinar P, Mobasher M, Ziogas A, Meyskens FL, Anton-Culver H. PMID: 18165642.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    58. Another negative chemoprevention trial: what can we learn? Clin Cancer Res. 2008 Jan 01; 14(1):2-3. Meyskens FL. PMID: 18172244.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    59. Redox effector factor-1, combined with reactive oxygen species, plays an important role in the transformation of JB6 cells. Carcinogenesis. 2007 Nov; 28(11):2382-90. Yang S, Misner BJ, Chiu RJ, Meyskens FL. PMID: 17566060.
      View in: PubMed   Mentions: 22     Fields:    Translation:AnimalsCells
    60. Development of a polyamine database for assessing dietary intake. J Am Diet Assoc. 2007 Jun; 107(6):1024-7. Zoumas-Morse C, Rock CL, Quintana EL, Neuhouser ML, Gerner EW, Meyskens FL. PMID: 17524725; PMCID: PMC2848593.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimals
    61. Rationale for, and design of, a clinical trial targeting polyamine metabolism for colon cancer chemoprevention. Amino Acids. 2007 Aug; 33(2):189-95. Gerner EW, Meyskens FL, Goldschmid S, Lance P, Pelot D. PMID: 17396214.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    62. Reactive oxygen species: a breath of life or death? Clin Cancer Res. 2007 Feb 01; 13(3):789-94. Fruehauf JP, Meyskens FL. PMID: 17289868.
      View in: PubMed   Mentions: 325     Fields:    Translation:HumansCells
    63. Cancer following total joint arthroplasty. Cancer Epidemiol Biomarkers Prev. 2007 Feb; 16(2):356. Meyskens F. PMID: 17301272.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    64. A novel three-dimensional model to quantify metastatic melanoma invasion. Mol Cancer Ther. 2007 Feb; 6(2):552-61. Ghajar CM, Suresh V, Peyton SR, Raub CB, Meyskens FL, George SC, Putnam AJ. PMID: 17267658.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    65. New perspectives on melanoma pathogenesis and chemoprevention. Recent Results Cancer Res. 2007; 174:191-5. Meyskens FL, Farmer PJ, Yang S, Anton-Culver H. PMID: 17302196.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    66. American Society of Preventive Oncology Distinguished Career Achievement Lecture 2006--Enjoy the journey: the long and winding road of chemoprevention agent development. Cancer Epidemiol Biomarkers Prev. 2006 Nov; 15(11):2038-41. Meyskens FL. PMID: 17119025.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    67. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward. Clin Cancer Res. 2006 Jun 15; 12(12):3661-97. Kelloff GJ, Lippman SM, Dannenberg AJ, Sigman CC, Pearce HL, Reid BJ, Szabo E, Jordan VC, Spitz MR, Mills GB, Papadimitrakopoulou VA, Lotan R, Aggarwal BB, Bresalier RS, Kim J, Arun B, Lu KH, Thomas ME, Rhodes HE, Brewer MA, Follen M, Shin DM, Parnes HL, Siegfried JM, Evans AA, Blot WJ, Chow WH, Blount PL, Maley CC, Wang KK, Lam S, Lee JJ, Dubinett SM, Engstrom PF, Meyskens FL, O'Shaughnessy J, Hawk ET, Levin B, Nelson WG, Hong WK, AACR Task Force on Cancer Prevention. PMID: 16778094.
      View in: PubMed   Mentions: 89     Fields:    Translation:HumansCells
    68. Predicting risk for the appearance of melanoma. J Clin Oncol. 2006 Aug 01; 24(22):3522-3. Meyskens FL, Ransohoff DF. PMID: 16728487.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    69. Microphthalmic-associated transcription factor integrates melanocyte biology and melanoma progression. Clin Cancer Res. 2006 Feb 15; 12(4):1069-73. Goding C, Meyskens FL. PMID: 16489058.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    70. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor. Mol Cancer Ther. 2005 Dec; 4(12):1923-35. Yang S, Irani K, Heffron SE, Jurnak F, Meyskens FL. PMID: 16373707.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    71. Principles of cancer prevention. Semin Oncol Nurs. 2005 Nov; 21(4):229-35. Meyskens FL, Tully P. PMID: 16293510.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    72. Talking to a patient. J Clin Oncol. 2005 Jul 01; 23(19):4463-4. Meyskens FL, Hietanen P, Tannock IF. PMID: 15994158.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    73. Diet and cancer: the disconnect between epidemiology and randomized clinical trials. Cancer Epidemiol Biomarkers Prev. 2005 Jun; 14(6):1366-9. Meyskens FL, Szabo E. PMID: 15941942.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsPHPublic Health
    74. Diet and melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev. 2005 Jan; 14(1):293. Meyskens FL, Farmer PJ, Anton-Culver H. PMID: 15668513.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    75. Redox regulation by intrinsic species and extrinsic nutrients in normal and cancer cells. Annu Rev Nutr. 2005; 25:261-95. McEligot AJ, Yang S, Meyskens FL. PMID: 16011468.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    76. How should we move the field of chemopreventive agent development forward in a productive manner? Recent Results Cancer Res. 2005; 166:113-24. Meyskens FL, Szabo E. PMID: 15648187.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    77. Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells. J Med Chem. 2004 Dec 30; 47(27):6914-20. Cen D, Brayton D, Shahandeh B, Meyskens FL, Farmer PJ. PMID: 15615540.
      View in: PubMed   Mentions: 101     Fields:    Translation:HumansCells
    78. Nuclear morphometry and molecular biomarkers of actinic keratosis, sun-damaged, and nonexposed skin. Cancer Epidemiol Biomarkers Prev. 2004 Dec; 13(12):1996-2002. Carpenter PM, Linden KG, McLaren CE, Li KT, Arain S, Barr RJ, Hite P, Sun JD, Meyskens FL. PMID: 15598753.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    79. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J Natl Cancer Inst. 2004 Dec 01; 96(23):1743-50. Goodman GE, Thornquist MD, Balmes J, Cullen MR, Meyskens FL, Omenn GS, Valanis B, Williams JH. PMID: 15572756.
      View in: PubMed   Mentions: 137     Fields:    Translation:HumansCTClinical Trials
    80. Alterations in activating protein 1 composition correlate with phenotypic differentiation changes induced by resveratrol in human melanoma. Mol Pharmacol. 2005 Jan; 67(1):298-308. Yang S, Meyskens FL. PMID: 15492115.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    81. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer. 2004 Oct; 4(10):781-92. Gerner EW, Meyskens FL. PMID: 15510159.
      View in: PubMed   Mentions: 439     Fields:    Translation:Humans
    82. Pulling the trigger. J Clin Oncol. 2004 Sep 01; 22(17):3644-5. Meyskens FL, Fetting JH. PMID: 15337815.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    83. Etiologic pathogenesis of melanoma: a unifying hypothesis for the missing attributable risk. Clin Cancer Res. 2004 Apr 15; 10(8):2581-3. Meyskens FL, Farmer PJ, Anton-Culver H. PMID: 15102657.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    84. Comparative expression of NFkappaB proteins in melanocytes of normal skin vs. benign intradermal naevus and human metastatic melanoma biopsies. Pigment Cell Res. 2004 Apr; 17(2):173-80. McNulty SE, del Rosario R, Cen D, Meyskens FL, Yang S. PMID: 15016307.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    85. During human melanoma progression AP-1 binding pairs are altered with loss of c-Jun in vitro. Pigment Cell Res. 2004 Feb; 17(1):74-83. Yang S, McNulty S, Meyskens FL. PMID: 14717848.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    86. Cervical cancer chemoprevention, vaccines, and surrogate endpoint biomarkers. Cancer. 2003 Nov 01; 98(9 Suppl):2044-51. Follen M, Meyskens FL, Alvarez RD, Walker JL, Bell MC, Storthz KA, Sastry J, Roy K, Richards-Kortum R, Cornelison TL. PMID: 14603541.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    87. Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment. Laryngoscope. 2003 Oct; 113(10):1687-702. Armstrong WB, Wan XS, Kennedy AR, Taylor TH, Meyskens FL. PMID: 14520092.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    88. Adenoma recurrences after resection of colorectal carcinoma: results from the Southwest Oncology Group 9041 calcium chemoprevention pilot study. Ann Surg Oncol. 2003 Oct; 10(8):870-5. Chu DZ, Chansky K, Alberts DS, Meyskens FL, Fenoglio-Preiser CM, Rivkin SE, Mills GM, Giguere JK, Goodman GE, Abbruzzese JL, Lippman SM. PMID: 14527904.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    89. Point: Surrogate end point biomarkers are likely to be limited in their usefulness in the development of cancer chemoprevention agents against sporadic cancers. Cancer Epidemiol Biomarkers Prev. 2003 Jul; 12(7):589-92. Armstrong WB, Taylor TH, Meyskens FL. PMID: 12869395.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    90. Melanin as a target for melanoma chemotherapy: pro-oxidant effect of oxygen and metals on melanoma viability. Pigment Cell Res. 2003 Jun; 16(3):273-9. Farmer PJ, Gidanian S, Shahandeh B, Di Bilio AJ, Tohidian N, Meyskens FL. PMID: 12753401.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    91. Management of human melanoma: what has the last decade wrought? Oncologist. 2003; 8(5):448-50. Meyskens FL. PMID: 14530497.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    92. Why phase II trials in cervical chemoprevention are negative: what have we learned? Cancer Causes Control. 2002 Nov; 13(9):855-73. Follen M, Vlastos AT, Meyskens FL, Atkinson EN, Schottenfeld D. PMID: 12462551.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    93. Disulfiram induces apoptosis in human melanoma cells: a redox-related process. Mol Cancer Ther. 2002 Jan; 1(3):197-204. Cen D, Gonzalez RI, Buckmeier JA, Kahlon RS, Tohidian NB, Meyskens FL. PMID: 12467214.
      View in: PubMed   Mentions: 51     Fields:    Translation:Cells
    94. Development of Bowman-Birk inhibitor for chemoprevention of oral head and neck cancer. Ann N Y Acad Sci. 2001 Dec; 952:116-23. Meyskens FL. PMID: 11795430.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    95. RelA, p50 and inhibitor of kappa B alpha are elevated in human metastatic melanoma cells and respond aberrantly to ultraviolet light B. Pigment Cell Res. 2001 Dec; 14(6):456-65. McNulty SE, Tohidian NB, Meyskens FL. PMID: 11775058.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    96. Aberrant redox regulation in human metastatic melanoma cells compared to normal melanocytes. Free Radic Biol Med. 2001 Sep 15; 31(6):799-808. Meyskens FL, McNulty SE, Buckmeier JA, Tohidian NB, Spillane TJ, Kahlon RS, Gonzalez RI. PMID: 11557318.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    97. Redox regulation in human melanocytes and melanoma. Pigment Cell Res. 2001 Jun; 14(3):148-54. Meyskens FL, Farmer P, Fruehauf JP. PMID: 11434561.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansAnimalsCells
    98. Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations. Urology. 2001 Apr; 57(4 Suppl 1):4-27. Lieberman R, Nelson WG, Sakr WA, Meyskens FL, Klein EA, Wilding G, Partin AW, Lee JJ, Lippman SM. PMID: 11295590.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    99. Potential target populations and clinical models for testing chemopreventive agents. Urology. 2001 Apr; 57(4 Suppl 1):171-3. Klein EA, Meyskens FL. PMID: 11295619.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    100. African American men and hereditary/familial prostate cancer: Intermediate-risk populations for chemoprevention trials. Urology. 2001 Apr; 57(4 Suppl 1):178-81. Powell IJ, Meyskens FL. PMID: 11295621.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    101. Alpha-difluoromethylornithine and polyamine levels in the human prostate: results of a phase IIa trial. J Natl Cancer Inst. 2001 Jan 03; 93(1):57-9. Simoneau AR, Gerner EW, Phung M, McLaren CE, Meyskens FL. PMID: 11136843.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    102. Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial. Clin Cancer Res. 2000 Dec; 6(12):4684-91. Armstrong WB, Kennedy AR, Wan XS, Taylor TH, Nguyen QA, Jensen J, Thompson W, Lagerberg W, Meyskens FL. PMID: 11156220.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCTClinical Trials
    103. Cancer prevention in the year 2025: an anticipation. Eur J Cancer. 2000 Sep; 36(14):1737-40. Meyskens FL. PMID: 10974620.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    104. Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial. Psychooncology. 2000 Jul-Aug; 9(4):340-54. Moinpour CM, Sawyers Triplett J, McKnight B, Lovato LC, Upchurch C, Leichman CG, Muggia FM, Tanaka L, James WA, Lennard M, Meyskens FL. PMID: 10960931.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    105. Cancer population genetics and tumour prevention: an unfulfilled paradigm. Eur J Cancer. 2000 Jun; 36(10):1189-92. Meyskens FL. PMID: 10882855.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    106. WHO consensus conference on diet and cancer. Members of the breast cancer panel. Eur J Cancer Prev. 2000 Jun; 9(3):213-6. Meyskens FL, Jungi WF, Gerber M, de Waard F, Heidemann E, Heim ME, Joossens JV, Salvini S, Trichopoulou A, Varela G, Wolfram G. PMID: 10954261.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    107. Chemoprevention of head and neck cancer. Otolaryngol Head Neck Surg. 2000 May; 122(5):728-35. Armstrong WB, Meyskens FL. PMID: 10793355.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    108. Chemoprevention of breast and colon cancer. Curr Oncol Rep. 2000 May; 2(3):223-4. Meyskens FL. PMID: 11122846.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    109. Re: Vitamin A analogue for breast cancer prevention: a grade of F or incomplete? J Natl Cancer Inst. 2000 Feb 02; 92(3):274-5. Meyskens FL. PMID: 10655448.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    110. Criteria for implementation of large and multiagent clinical chemoprevention trials. J Cell Biochem Suppl. 2000; 34:115-20. Meyskens FL. PMID: 10762023.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    111. Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia. Cancer Epidemiol Biomarkers Prev. 2000 Jan; 9(1):43-7. Armstrong WB, Kennedy AR, Wan XS, Atiba J, McLaren CE, Meyskens FL. PMID: 10667462.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    112. Relationship between protease activity and neu oncogene expression in patients with oral leukoplakia treated with the Bowman Birk Inhibitor. Cancer Epidemiol Biomarkers Prev. 1999 Jul; 8(7):601-8. Wan XS, Meyskens FL, Armstrong WB, Taylor TH, Kennedy AR. PMID: 10428197.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    113. Activation of nuclear factor-kappa B in human metastatic melanomacells and the effect of oxidative stress. Clin Cancer Res. 1999 May; 5(5):1197-202. Meyskens FL, Buckmeier JA, McNulty SE, Tohidian NB. PMID: 10353757.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    114. Development of difluoromethylornithine (DFMO) as a chemoprevention agent. Clin Cancer Res. 1999 May; 5(5):945-51. Meyskens FL, Gerner EW. PMID: 10353725.
      View in: PubMed   Mentions: 110     Fields:    Translation:HumansAnimalsCells
    115. Re: Cancer chemoprevention: progress and promise. J Natl Cancer Inst. 1999 Mar 17; 91(6):563-5. Meyskens FL. PMID: 10088631.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    116. Chemoprevention of human cancer: a reasonable strategy? Recent Results Cancer Res. 1999; 151:113-21. Meyskens FL. PMID: 10337722.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    117. A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group study. Cancer J Sci Am. 1999 Jan-Feb; 5(1):41-7. Sondak VK, Liu PY, Flaherty LE, Fletcher WS, Periman P, Gandara DR, Taylor SA, Balcerzak SP, Meyskens FL. PMID: 10188060.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    118. Quality of life in advanced prostate cancer: results of a randomized therapeutic trial. J Natl Cancer Inst. 1998 Oct 21; 90(20):1537-44. Moinpour CM, Savage MJ, Troxel A, Lovato LC, Eisenberger M, Veith RW, Higgins B, Skeel R, Yee M, Blumenstein BA, Crawford ED, Meyskens FL. PMID: 9790546.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    119. Principles of human chemoprevention. Hematol Oncol Clin North Am. 1998 Oct; 12(5):935-41, v. Meyskens FL. PMID: 9888014.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    120. Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention. J Natl Cancer Inst. 1998 Aug 19; 90(16):1212-8. Meyskens FL, Gerner EW, Emerson S, Pelot D, Durbin T, Doyle K, Lagerberg W. PMID: 9719082.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    121. Strategies for recruitment to a population-based lung cancer prevention trial: the CARET experience with heavy smokers. Beta-Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev. 1998 May; 7(5):405-12. Goodman GE, Valanis B, Meyskens FL, Williams JH, Metch BJ, Thornquist MD, Omenn GS. PMID: 9610790.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    122. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study. Cancer Res. 1998 Mar 15; 58(6):1149-58. Ahnen DJ, Feigl P, Quan G, Fenoglio-Preiser C, Lovato LC, Bunn PA, Stemmerman G, Wells JD, Macdonald JS, Meyskens FL. PMID: 9515799.
      View in: PubMed   Mentions: 89     Fields:    Translation:HumansCTClinical Trials
    123. Phase II trial of oral beta-all trans-retinoic acid in hepatocellular carcinoma (SWOG 9157). Invest New Drugs. 1998; 16(2):171-3. Meyskens FL, Jacobson J, Nguyen B, Weiss GR, Gandara DR, MacDonald JS. PMID: 9848581.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    124. Luminol-enhanced chemiluminescent response of human melanocytes and melanoma cells to hydrogen peroxide stress. Pigment Cell Res. 1997 Jun; 10(3):184-9. Meyskens FL, Chau HV, Tohidian N, Buckmeier J. PMID: 9266607.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    125. Improving breast self-examination compliance: a Southwest Oncology Group randomized trial of three interventions. Prev Med. 1997 May-Jun; 26(3):320-32. Strickland CJ, Feigl P, Upchurch C, King DK, Pierce HI, Grevstad PK, Bearden JD, Dawson M, Loewen WC, Meyskens FL. PMID: 9144756.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    126. Restoration of oral all-trans retinoic acid bioavailability after a brief drug holiday. Am J Ther. 1997 Apr; 4(4):134-40. Atiba JO, Manzardo AM, Thiruvengadam R, Schell MJ, Meyskens FL. PMID: 10423603.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    127. A study of reproductive function in patients with seminoma treated with radiotherapy and orchidectomy: (SWOG-8711). Southwest Oncology Group. Int J Radiat Oncol Biol Phys. 1997 Apr 01; 38(1):83-94. Gordon W, Siegmund K, Stanisic TH, McKnight B, Harris IT, Carroll PR, Paradelo JC, Meyers FJ, Chapman RA, Meyskens FL. PMID: 9212008.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    128. Correction--malignant glioma. J Clin Oncol. 1997 Mar; 15(3):1286-7. Atiba JO, Meyskens FL. PMID: 9060576.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    129. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst. 1996 Nov 06; 88(21):1550-9. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Cherniack MG, Brodkin CA, Hammar S. PMID: 8901853.
      View in: PubMed   Mentions: 230     Fields:    Translation:HumansCTClinical Trials
    130. Chemoprevention of lung cancer: the beta-Carotene and Retinol Efficacy Trial (CARET) in high-risk smokers and asbestos-exposed workers. IARC Sci Publ. 1996; (136):67-85. Omenn GS, Goodman G, Thornquist M, Barnhart S, Balmes J, Cherniack M, Cullen M, Glass A, Keogh J, Liu D, Meyskens F, Perloff M, Valanis B, Williams J. PMID: 8791118.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    131. Prevention of cervical intraepithelial neoplasia and cervical cancer. Am J Clin Nutr. 1995 12; 62(6 Suppl):1417S-1419S. Meyskens FL, Manetta A. PMID: 7495240.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    132. Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study. J Natl Cancer Inst. 1995 Nov 15; 87(22):1710-3. Meyskens FL, Kopecky KJ, Taylor CW, Noyes RD, Tuthill RJ, Hersh EM, Feun LG, Doroshow JH, Flaherty LE, Sondak VK. PMID: 7473820.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCTClinical Trials
    133. Effects of vitamin A on survival in patients with chronic myelogenous leukemia: a SWOG randomized trial. Leuk Res. 1995 Sep; 19(9):605-12. Meyskens FL, Kopecky KJ, Appelbaum FR, Balcerzak SP, Samlowski W, Hynes H. PMID: 7564470.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    134. Chemoprevention of cervical cancer with folic acid: a phase III Southwest Oncology Group Intergroup study. Cancer Epidemiol Biomarkers Prev. 1995 Mar; 4(2):155-9. Childers JM, Chu J, Voigt LF, Feigl P, Tamimi HK, Franklin EW, Alberts DS, Meyskens FL. PMID: 7742723.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    135. Development of difluoromethylornithine as a chemoprevention agent for the management of colon cancer. J Cell Biochem Suppl. 1995; 22:126-31. Meyskens FL, Gerner EW. PMID: 8538189.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    136. Evaluation and treatment of the patient with early melanoma. Compr Ther. 1995; 21(1):46-50. Jakowatz JG, Meyskens FL. PMID: 7697982.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    137. Randomized trial of vitamin A versus observation as adjuvant therapy in high-risk primary malignant melanoma: a Southwest Oncology Group study. J Clin Oncol. 1994 Oct; 12(10):2060-5. Meyskens FL, Liu PY, Tuthill RJ, Sondak VK, Fletcher WS, Jewell WR, Samlowski W, Balcerzak SP, Rector DJ, Noyes RD, et al. PMID: 7931474.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    138. Dose de-escalation chemoprevention trial of alpha-difluoromethylornithine in patients with colon polyps. J Natl Cancer Inst. 1994 Aug 03; 86(15):1122-30. Meyskens FL, Emerson SS, Pelot D, Meshkinpour H, Shassetz LR, Einspahr J, Alberts DS, Gerner EW. PMID: 8028034.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    139. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J Natl Cancer Inst. 1994 Apr 06; 86(7):539-43. Meyskens FL, Surwit E, Moon TE, Childers JM, Davis JR, Dorr RT, Johnson CS, Alberts DS. PMID: 8133537.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCTClinical Trials
    140. Comparative exposure ratios: a non-parametric, multifactor technique for case-control studies. Stat Med. 1994 Feb 15; 13(3):245-60. Aickin M, Ritenbaugh C, Surwit E, Meyskens F. PMID: 8202651.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    141. Alterations in gene expression and signal transductions in human melanocytes and melanoma cells. Crit Rev Oncog. 1994; 5(5):429-50. Yamanishi DT, Meyskens FL. PMID: 8519807.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    142. Oral cancer prevention: the case for carotenoids and anti-oxidant nutrients. Prev Med. 1993 Sep; 22(5):701-11. Garewal H, Meyskens F, Friedman S, Alberts D, Ramsey L. PMID: 8234210.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    143. Ventral mesencephalic and cortical transplants into the rat striatum display enhanced activity for neutral endopeptidase 24.11 ('enkephalinase'; CALLA). Brain Res. 1993 May 28; 612(1-2):85-95. Back SA, Colon M, Fallon JH, Meyskens FL, Loughlin SE. PMID: 8330216.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    144. Retinoids as anticancer agents. J Clin Oncol. 1993 Mar; 11(3):588-9. Meyskens FL. PMID: 8445437.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    145. Protein kinase C beta expression in melanoma cells and melanocytes: differential expression correlates with biological responses to 12-O-tetradecanoylphorbol 13-acetate. J Cancer Res Clin Oncol. 1993; 119(4):199-206. Powell MB, Rosenberg RK, Graham MJ, Birch ML, Yamanishi DT, Buckmeier JA, Meyskens FL. PMID: 7678596.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    146. Comparison of calmodulin gene expression in human neonatal melanocytes and metastatic melanoma cell lines. J Invest Dermatol. 1992 Dec; 99(6):764-73. Hickie RA, Graham MJ, Buckmeier JA, Meyskens FL. PMID: 1469290.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    147. Differences in basic fibroblast growth factor RNA and protein levels in human primary melanocytes and metastatic melanoma cells. Cancer Res. 1992 Sep 15; 52(18):5024-9. Yamanishi DT, Graham MJ, Florkiewicz RZ, Buckmeier JA, Meyskens FL. PMID: 1516057.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    148. Chemoprevention of breast cancer. Semin Oncol. 1992 Jun; 19(3):220-9. Atiba JO, Meyskens FL. PMID: 1609290.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    149. Isn't skin cancer preventable? J Natl Cancer Inst. 1992 Mar 04; 84(5):286-7. Meyskens FL. PMID: 1738176.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    150. Coexpression of vimentin and keratins by human melanoma tumor cells: correlation with invasive and metastatic potential. J Natl Cancer Inst. 1992 Feb 05; 84(3):165-74. Hendrix MJ, Seftor EA, Chu YW, Seftor RE, Nagle RB, McDaniel KM, Leong SP, Yohem KH, Leibovitz AM, Meyskens FL, et al. PMID: 1371813.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansAnimalsCells
    151. Strategies for prevention of cancer in humans. Oncology (Williston Park). 1992 Feb; 6(2 Suppl):15-24. Meyskens FL. PMID: 1532731.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    152. Retinoids and carotenoids in the prevention of oral cancer: a critical appraisal. Cancer Epidemiol Biomarkers Prev. 1992 Jan-Feb; 1(2):155-9. Garewal HS, Meyskens F. PMID: 1306099.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    153. Biomarker intermediate endpoints and cancer prevention. J Natl Cancer Inst Monogr. 1992; (13):177-81. Meyskens FL. PMID: 1389691.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    154. Polyamine contents in rectal and buccal mucosae in humans treated with oral difluoromethylornithine. Cancer Epidemiol Biomarkers Prev. 1992 Jan-Feb; 1(2):131-5. Boyle JO, Meyskens FL, Garewal HS, Gerner EW. PMID: 1306095.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    155. A quantitatively scored cancer-risk assessment tool: its development and use. J Cancer Educ. 1992; 7(1):15-36. Lippman SM, Bassford TL, Meyskens FL. PMID: 1571244.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    156. Expression of c-jun, jun-B, and c-fos proto-oncogenes in human primary melanocytes and metastatic melanomas. J Invest Dermatol. 1991 Aug; 97(2):349-53. Yamanishi DT, Buckmeier JA, Meyskens FL. PMID: 1712822.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    157. A community-based feasibility study using wheat bran fiber supplementation to lower colon cancer risk. Prev Med. 1991 Mar; 20(2):213-25. Ho EE, Atwood JR, Benedict J, Ritenbaugh C, Sheehan ET, Abrams C, Alberts D, Meyskens FL. PMID: 1647531.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCTClinical Trials
    158. Chemoprevention of cancer. Hematol Oncol Clin North Am. 1991 Feb; 5(1):69-77. Garewal HS, Meyskens FL. PMID: 2026569.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    159. Chemoprevention of human skin cancers. Semin Oncol Nurs. 1991 Feb; 7(1):45-52. Loescher LJ, Meyskens FL. PMID: 2011658.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    160. The differential expression of protein kinase C genes in normal human neonatal melanocytes and metastatic melanomas. Carcinogenesis. 1991 Jan; 12(1):105-9. Yamanishi DT, Graham M, Buckmeier JA, Meyskens FL. PMID: 1988168.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    161. An exploratory study of attitudes, beliefs and practices related to the interim dietary guidelines for reducing cancer in the elderly. J Nutr Elder. 1991; 10(4):31-49. Ho EE, Lee FC, Meyskens FL. PMID: 1920044.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    162. Beta-carotene didn't prevent cancer: what's up doc? J Natl Cancer Inst. 1990 Dec 05; 82(23):1851-3. Garewal H, Meyskens FL. PMID: 2078244.
      View in: PubMed   Mentions:    Fields:    
    163. Response of oral leukoplakia to beta-carotene. J Clin Oncol. 1990 Oct; 8(10):1715-20. Garewal HS, Meyskens FL, Killen D, Reeves D, Kiersch TA, Elletson H, Strosberg A, King D, Steinbronn K. PMID: 2213107.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    164. Coming of age--the chemoprevention of cancer. N Engl J Med. 1990 Sep 20; 323(12):825-7. Meyskens FL. PMID: 2202903.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    165. Radiosensitivity of murine and human melanoma cells: a comparative study with different models. Pigment Cell Res. 1990 Sep; 3(3):157-61. Yohem KH, Slymen DJ, Bregman MD, Meyskens FL. PMID: 2290787.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    166. Phase II study of fenretinide (N-[4-hydroxyphenyl]retinamide) in advanced breast cancer and melanoma. Invest New Drugs. 1990 Aug; 8(3):317-9. Modiano MR, Dalton WS, Lippman SM, Joffe L, Booth AR, Meyskens FL. PMID: 2148744.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    167. Polyamine biosynthesis inhibitors combined with systemic hyperthermia in cancer therapy. Int J Radiat Oncol Biol Phys. 1990 Jul; 19(1):89-96. Harari PM, Fuller DJ, Carper SW, Croghan MK, Meyskens FL, Shimm DS, Gerner EW. PMID: 2116388.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    168. Effect of single dose ionizing radiation on the cellular proliferation and apparent radiosensitivity of melanoma. Anticancer Res. 1990 Jul-Aug; 10(4):1079-82. Yohem KH, Bregman MD, Meyskens FL. PMID: 2382980.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    169. Recombinant human interferon gamma: adverse effects in high-risk stage I and II cutaneous malignant melanoma. J Natl Cancer Inst. 1990 Jun 20; 82(12):1071. Meyskens FL, Kopecky K, Samson M, Hersh E, Macdonald J, Jaffe H, Crowley J, Coltman C. PMID: 2112201.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    170. Ocular toxic effects of fenretinide. J Natl Cancer Inst. 1990 Jun 20; 82(12):1063. Modiano MR, Dalton WS, Lippman SM, Joffe L, Booth AR, Meyskens FL. PMID: 2140863.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    171. The place of chemoprevention studies in cancer prevention planning. Prog Clin Biol Res. 1990; 346:135-43. Meyskens FL. PMID: 2197622.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    172. Development of a contingency recruitment plan for a phase III chemoprevention trial of cervical dysplasia. Prog Clin Biol Res. 1990; 339:151-63. Loescher LJ, Graham VE, Aickin M, Meyskens FL, Surwit EA. PMID: 2202990.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    173. Replating efficiency of metastatic melanoma cells from lymph node and subcutaneous sites does not predict patient survival. Clin Exp Metastasis. 1989 Nov-Dec; 7(6):627-32. Meyskens FL, Thomson SP, Buckmeier J. PMID: 2776367.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    174. Surviving adult cancers. Part 2: Psychosocial implications. Ann Intern Med. 1989 Sep 15; 111(6):517-24. Welch-McCaffrey D, Hoffman B, Leigh SA, Loescher LJ, Meyskens FL. PMID: 2672926.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    175. Surviving adult cancers. Part 1: Physiologic effects. Ann Intern Med. 1989 Sep 01; 111(5):411-32. Loescher LJ, Welch-McCaffrey D, Leigh SA, Hoffman B, Meyskens FL. PMID: 2669594.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    176. The role of serum and tissue pharmacology studies in the design and interpretation of chemoprevention trials. Prev Med. 1989 Sep; 18(5):680-7. Plezia PM, Alberts DS, Peng YM, Xu MJ, Sayers S, Davis TP, Surwit EA, Meyskens FL. PMID: 2694162.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    177. Retinoids as potential chemopreventive agents in squamous cell carcinoma of the head and neck. Prev Med. 1989 Sep; 18(5):740-8. Lippman SM, Garewal HS, Meyskens FL. PMID: 2694167.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    178. Cloning efficiency of human melanoma cells is modulated after invasion through a reconstituted basement membrane. Cancer Lett. 1989 May; 45(2):135-43. Yohem KH, Seftor EA, Meyskens FL, Hendrix MJ. PMID: 2731157.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    179. Quality of life end points in cancer clinical trials: review and recommendations. J Natl Cancer Inst. 1989 Apr 05; 81(7):485-95. Moinpour CM, Feigl P, Metch B, Hayden KA, Meyskens FL, Crowley J. PMID: 2646455.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    180. Cutaneous malignant melanoma. II. The natural history and prognostic factors influencing the development of stage II disease. Cancer. 1989 Apr 01; 63(7):1430-6. Berdeaux DH, Meyskens FL, Parks B, Tong T, Loescher L, Moon TE. PMID: 2920369.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    181. Immunohistochemical and ultrastructural study of human melanoma colonies grown in soft agar. Am J Anat. 1989 Mar; 184(3):212-24. Persky B, Meyskens FL, Hendrix MJ. PMID: 2750677.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    182. Identification of a recurring translocation site involving chromosome 6 in human malignant melanoma. Cancer Res. 1989 Jan 15; 49(2):420-3. Trent JM, Thompson FH, Meyskens FL. PMID: 2642739.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    183. Pharmacokinetics of N-4-hydroxyphenyl-retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients. Int J Cancer. 1989 Jan 15; 43(1):22-6. Peng YM, Dalton WS, Alberts DS, Xu MJ, Lim H, Meyskens FL. PMID: 2521335.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    184. Results of the use of vitamin A and retinoids in cutaneous malignancies. Pharmacol Ther. 1989; 40(1):107-22. Lippman SM, Meyskens FL. PMID: 2645584.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    185. Evolution of Cancer Prevention and Control Program at the Arizona Cancer Center. J Natl Cancer Inst. 1988 Dec 21; 80(20):1595-8. Meyskens FL. PMID: 3193477.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    186. Thinking about cancer causality and chemoprevention. J Natl Cancer Inst. 1988 Oct 19; 80(16):1278-81. Meyskens FL. PMID: 3172255.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    187. Cutaneous malignant melanoma (Arizona Cancer Center experience). I. Natural history and prognostic factors influencing survival in patients with stage I disease. Cancer. 1988 Sep 15; 62(6):1207-14. Meyskens FL, Berdeaux DH, Parks B, Tong T, Loescher L, Moon TE. PMID: 3409189.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    188. A phase I trial of recombinant interferon-alpha and alpha-difluoromethylornithine in metastatic melanoma. J Biol Response Mod. 1988 Aug; 7(4):409-15. Croghan MK, Booth A, Meyskens FL. PMID: 3139843.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    189. Human recombinant alpha- and gamma-interferons enhance the cytotoxic properties of tumor necrosis factor on human melanoma. J Biol Response Mod. 1988 Aug; 7(4):384-9. Bregman MD, Meyskens FL. PMID: 3139842.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    190. Nonsurgical treatments for skin cancer: retinoids and alpha-interferon. J Dermatol Surg Oncol. 1988 Aug; 14(8):862-9. Lippman SM, Shimm DS, Meyskens FL. PMID: 3294268.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    191. Vitamin A derivatives in the prevention and treatment of human cancer. J Am Coll Nutr. 1988 Aug; 7(4):269-84. Lippman SM, Meyskens FL. PMID: 3062055.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    192. Rethinking medical oncology training and education. J Clin Oncol. 1988 Mar; 6(3):561-2. Meyskens FL. PMID: 3351562.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    193. Biology of human melanoma colony-forming cells. Prog Clin Biol Res. 1988; 256:325-32. Meyskens FL. PMID: 3368492.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    194. Radiation survival of murine and human melanoma cells utilizing two assay systems: monolayer and soft agar. Br J Cancer. 1988 Jan; 57(1):64-9. Yohem KH, Slymen DJ, Bregman MD, Meyskens FL. PMID: 3348949; PMCID: PMC2246683.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    195. Retinoids as anticancer agents. Prog Clin Biol Res. 1988; 259:229-44. Lippman SM, Meyskens FL. PMID: 3283747.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    196. Tetrazolium staining by optical scanning overestimates colony size and number of colonies counted. Int J Cell Cloning. 1987 Nov; 5(6):472-9. Bregman MD, Buckmeier J, Meyskens FL. PMID: 3429933.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    197. Effect of tumor colony definition on ionizing radiation survival curves of melanoma-colony forming cells. Int J Radiat Oncol Biol Phys. 1987 Nov; 13(11):1725-33. Yohem KH, Bregman MD, Meyskens FL. PMID: 3667379.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    198. Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. Ann Intern Med. 1987 Oct; 107(4):499-502. Lippman SM, Meyskens FL. PMID: 3477106.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    199. Rationale and strategies for chemoprevention of cancer in humans. Cancer Res. 1987 Jun 01; 47(11):3012-31. Bertram JS, Kolonel LN, Meyskens FL. PMID: 3105872.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    200. Retinoids as preventive and therapeutic anticancer agents (Part II). Cancer Treat Rep. 1987 May; 71(5):493-515. Lippman SM, Kessler JF, Meyskens FL. PMID: 3552220.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    201. Retinoids as preventive and therapeutic anticancer agents (Part I). Cancer Treat Rep. 1987 Apr; 71(4):391-405. Lippman SM, Kessler JF, Meyskens FL. PMID: 3548957.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimalsCells
    202. Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides). Arch Dermatol. 1987 Feb; 123(2):201-4. Kessler JF, Jones SE, Levine N, Lynch PJ, Booth AR, Meyskens FL. PMID: 2949706.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    203. Median effect and long term recovery analysis of biological modifier interactions with difluoromethylornithine on the proliferation of human melanoma cells. Pigment Cell Res. 1987; 1(2):124-8. Bregman MD, Buckmeier J, Funk C, Meyskens FL. PMID: 3148916.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    204. Methodological development of dietary fiber intervention to lower colon cancer risk. Prog Clin Biol Res. 1987; 248:263-81. Ho EE, Atwood JR, Meyskens FL. PMID: 2823286.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    205. Clinical experience with topical tretinoin in the treatment of cervical dysplasia. J Am Acad Dermatol. 1986 Oct; 15(4 Pt 2):826-9. Meyskens FL, Surwit ES. PMID: 3534021.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    206. Role of topical tretinoin in melanoma and dysplastic nevi. J Am Acad Dermatol. 1986 Oct; 15(4 Pt 2):822-5. Meyskens FL, Edwards L, Levine NS. PMID: 3534020.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    207. Phase II trial of beta-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap. West J Med. 1986 Aug; 145(2):192-5. Graham V, Surwit ES, Weiner S, Meyskens FL. PMID: 3765597; PMCID: PMC1306873.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    208. Phase II trial of bisantrene in patients with metastatic melanoma. Cancer Treat Rep. 1986 Aug; 70(8):1037-8. Mackel C, Meyskens FL, Alberts DS. PMID: 3731151.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    209. 13-cis-retinoic acid in myelodysplastic syndromes. J Clin Oncol. 1986 Aug; 4(8):1282. Greenberg BR, Buzaid AC, Meyskens FL. PMID: 3525772.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    210. Biological characterization of an acid-sensitive growth factor from human platelets: role in the proliferation of human melanoma and bovine endothelial cells. Biochem Biophys Res Commun. 1986 Jul 31; 138(2):795-802. Sipes NJ, Meyskens FL, Bregman MD. PMID: 3741434.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    211. Actions of melanotropins on mouse melanoma cell growth in vitro. J Natl Cancer Inst. 1986 May; 76(5):857-63. Abdel Malek ZA, Hadley ME, Bregman MD, Meyskens FL, Hruby VJ. PMID: 3009949.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    212. Regression of aggressive laryngeal papillomatosis with 13-cis-retinoic acid (accutane). J Biol Response Mod. 1986 Apr; 5(2):124-8. Alberts DS, Coulthard SW, Meyskens FL. PMID: 3461133.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    213. Difluoromethylornithine enhances inhibition of melanoma cell growth in soft agar by dexamethasone, clone A interferon and retinoic acid. Int J Cancer. 1986 Jan 15; 37(1):101-7. Bregman MD, Meyskens FL. PMID: 3079741.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    214. A phase I trial of topically applied trans-retinoic acid in cervical dysplasia-clinical efficacy. Invest New Drugs. 1986; 4(3):241-4. Weiner SA, Surwit EA, Graham VE, Meyskens FL. PMID: 3818228.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    215. Cervical tissue uptake of all-trans-retinoic acid delivered via a collagen sponge-cervical cap delivery device in patients with cervical dysplasia. Invest New Drugs. 1986; 4(3):245-9. Peng YM, Alberts DS, Graham V, Surwit EA, Weiner S, Meyskens FL. PMID: 3818229.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    216. Stimulation of human metastatic melanoma colony-forming cells by an acid-sensitive factor in human platelet sonicate. Cancer Res. 1985 Dec; 45(12 Pt 1):6268-72. Sipes NJ, Bregman MD, Meyskens FL. PMID: 3864528.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    217. Phase I-II study of 13-cis-retinoic acid in myelodysplastic syndrome. Cancer Treat Rep. 1985 Dec; 69(12):1369-74. Greenberg BR, Durie BG, Barnett TC, Meyskens FL. PMID: 3865701.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    218. In vitro quantification of melanoma tumor cell invasion. Clin Exp Metastasis. 1985 Oct-Dec; 3(4):221-33. Hendrix MJ, Gehlsen KR, Wagner HN, Rodney SR, Misiorowski RL, Meyskens FL. PMID: 4075611.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    219. Anchorage-independent growth of murine melanoma in serum-less media is dependent on insulin or melanocyte-stimulating hormone. Exp Cell Res. 1985 Apr; 157(2):419-28. Bregman MD, Abdel Malek ZA, Meyskens FL. PMID: 3920061.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    220. Dexamethasone and zinc in combination inhibit the anchorage-independent growth of S-91 Cloudman murine melanoma. Life Sci. 1985 Mar 04; 36(9):823-7. Kreutzfeld KL, Lei KY, Bregman MD, Meyskens FL. PMID: 3974412.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    221. Similar self-renewal properties for different sizes of human primary melanoma colonies replated in agar. Cancer Res. 1985 Mar; 45(3):1101-7. Meyskens FL, Thomson SP, Moon TE. PMID: 3882224.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    222. 13-Cis-retinoic acid: pharmacology, toxicology, and clinical applications for the prevention and treatment of human cancer. Crit Rev Oncol Hematol. 1985; 3(1):75-101. Meyskens FL, Goodman GE, Alberts DS. PMID: 3893773.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    223. Relation of in vitro colony survival to clinical response in a prospective trial of single-agent chemotherapy for metastatic melanoma. J Clin Oncol. 1984 Nov; 2(11):1223-8. Meyskens FL, Loescher L, Moon TE, Takasugi B, Salmon SE. PMID: 6387058.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    224. Kinetics of clonogenic melanoma cell proliferation and the limits on growth within a bilayer agar system. J Cell Physiol. 1984 Oct; 121(1):114-24. Thomson SP, Moon TE, Meyskens FL. PMID: 6480705.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    225. Oral isotretinoin therapy. Use in a patient with multiple cutaneous squamous cell carcinomas and keratoacanthomas. Arch Dermatol. 1984 Sep; 120(9):1215-7. Levine N, Miller RC, Meyskens FL. PMID: 6591861.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    226. Quantitation of the number of cells within tumor colonies in semisolid medium and their growth as oblate spheroids. Cancer Res. 1984 Jan; 44(1):271-7. Meyskens FL, Thomson SP, Moon TE. PMID: 6690038.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    227. Potential biological explanation of stimulation of colony growth in semi-solid agar by cytotoxic agents. Br J Cancer. 1983 Dec; 48(6):863-8. Meyskens FL, Thomson SP, Hickie RA, Sipes NJ. PMID: 6360194; PMCID: PMC2011576.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    228. A phase I trial of beta-all-trans-retinoic acid delivered via a collagen sponge and a cervical cap for mild or moderate intraepithelial cervical neoplasia. J Natl Cancer Inst. 1983 Nov; 71(5):921-5. Meyskens FL, Graham V, Chvapil M, Dorr RT, Alberts DS, Surwit EA. PMID: 6580493.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    229. Dexamethasone, prostaglandin A, and retinoic acid modulation of murine and human melanoma cells grown in soft agar. J Natl Cancer Inst. 1983 Nov; 71(5):927-32. Bregman MD, Peters E, Sander D, Meyskens FL. PMID: 6580494.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    230. Management of Stage I cutaneous melanoma. Ariz Med. 1983 Nov; 40(11):768-72. Berdeaux DH, Moon TE, Meyskens FL. PMID: 6661064.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    231. Effect of 13-cis-retinoic acid and 4-hydroxyphenyl-all-trans-retinamide on human tumor colony formation in soft agar. Int J Cancer. 1983 Sep 15; 32(3):295-9. Meyskens FL, Alberts DS, Salmon SE. PMID: 6224747.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    232. Vitamin A: a potential inhibitor of human cancer. Semin Oncol. 1983 Sep; 10(3):281-9. Kummet T, Meyskens FL. PMID: 6364353.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    233. In vitro modulation of human and murine melanoma growth by prostanoid analogues. Prostaglandins. 1983 Sep; 26(3):449-56. Bregman MD, Meyskens FL. PMID: 6581509.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    234. Radiation sensitivity of clonogenic human melanoma cells. Lancet. 1983 Jul 23; 2(8343):219. Meyskens FL. PMID: 6135052.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    235. Phase II evaluation of amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: a University of Arizona and Southwest Oncology Group Study. Cancer Treat Rep. 1983 Jul-Aug; 67(7-8):697-700. Ahmann FR, Meyskens FL, Jones SE, Bukowski RM, Saiers JH, Ryan DH, Costanzi J, Vaughn CB, Coltman CA. PMID: 6688199.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    236. Treatment of cutaneous T-cell lymphoma (mycosis fungoides) with 13-cis-retinoic acid. Lancet. 1983 Jun 18; 1(8338):1345-7. Kessler JF, Meyskens FL, Levine N, Lynch PJ, Jones SE. PMID: 6134133.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    237. Inhibition of human malignant melanoma colony-forming cells in vitro by prostaglandin A1. Cancer Res. 1983 Apr; 43(4):1642-5. Bregman MD, Meyskens FL. PMID: 6572555.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    238. Phase II trial of the dopaminergic inhibitor pimozide in previously treated melanoma patients. Cancer Treat Rep. 1983 Feb; 67(2):155-7. Neifeld JP, Tormey DC, Baker MA, Meyskens FL, Taub RN. PMID: 6825122.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    239. Vitamin A: evidence for its preventive role in human cancer. Nutr Cancer. 1983; 5(2):96-106. Kummet T, Moon TE, Meyskens FL. PMID: 6359074.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    240. Scanning and transmission electron microscopic evaluation of human melanoma cells treated with adriamycin and actinomycin D. Scan Electron Microsc. 1983; (Pt 2):983-95. Persky B, Peters EM, Gehlsen KR, Sorrentino JM, Meyskens FL, Hendrix MJ. PMID: 6635583.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    241. In vitro chemosensitivities of human tumor stem cells to the Phase II drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and prospective in vivo correlations. Cancer Res. 1982 Nov; 42(11):4495-8. Ahmann FR, Meyskens FL, Moon TE, Durie BG, Salmon SE. PMID: 6897012.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    242. Methods for evaluating the morphological and immunohistochemical properties of human tumor colonies grown in soft agar. In Vitro. 1982 Nov; 18(11):929-36. Persky B, Thomson SP, Meyskens FL, Hendrix MJ. PMID: 6759369.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    243. Method for measurement of self-renewal capacity of clonogenic cells from biopsies of metastatic human malignant melanoma. Cancer Res. 1982 Nov; 42(11):4606-13. Thomson SP, Meyskens FL. PMID: 7127298.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    244. Evaluation of topically applied trans-retinoic acid in the treatment of cervical intraepithelial lesions. Am J Obstet Gynecol. 1982 Aug 01; 143(7):821-3. Surwit EA, Graham V, Droegemueller W, Alberts D, Chvapil M, Dorr RT, Davis JR, Meyskens FL. PMID: 7048932.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    245. Retinoids increase transglutaminase activity and inhibit ornithine decarboxylase activity in Chinese hamster ovary cells and in melanoma cells stimulated to differentiate. Proc Natl Acad Sci U S A. 1982 Jul; 79(13):4093-7. Scott KF, Meyskens FL, Russell DH. PMID: 6125941; PMCID: PMC346583.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    246. Activity of isotretinoin against squamous cell cancers and preneoplastic lesions. Cancer Treat Rep. 1982 Jun; 66(6):1315-9. Meyskens FL, Gilmartin E, Alberts DS, Levine NS, Brooks R, Salmon SE, Surwit EA. PMID: 6211233.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    247. Quantitation of drug sensitivity by human metastatic melanoma colony-forming units. Br J Cancer. 1981 Dec; 44(6):787-97. Meyskens FL, Moon TE, Dana B, Gilmartin E, Casey WJ, Chen HS, Franks DH, Young L, Salmon SE. PMID: 7326191; PMCID: PMC2010878.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    248. Modulation of abnormal growth by retinoids: a clinical perspective of the biological phenomenon. Life Sci. 1981 May 21; 28(21):2323-7. Meyskens FL. PMID: 7019614.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    249. Endocrine responsiveness in human melanocytes and melanoma cells in culture. J Natl Cancer Inst. 1981 May; 66(5):799-802. Fuller BB, Meyskens FL. PMID: 6262556.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    250. Update on in vitro testing on new drugs in ovarian cancer and melanoma. Cancer Treat Rep. 1981 May-Jun; 65(5-6):532-3. Salmon SE, Meyskens FL, Alberts DS, Soehnlen B, Young L. PMID: 7195308.
      View in: PubMed   Mentions: 1     Fields:    
    251. Inhibition of human tumor colony formation by retinoids. Ann N Y Acad Sci. 1981 Feb 27; 359:414. Meyskens FL, Salmon SE. PMID: 6942692.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    252. New drugs in ovarian cancer and malignant melanoma: in vitro phase II screening with the human tumor stem cell assay. Cancer Treat Rep. 1981 Jan-Feb; 65(1-2):1-12. Salmon SE, Meyskens FL, Alberts DS, Soehnlen B, Young L. PMID: 7226159.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    253. Modulation of clonogenic human melanoma cells by follicle-stimulating hormone, melatonin, and nerve growth factor. Br J Cancer. 1981 Jan; 43(1):111-5. Meyskens FL, Salmon SE. PMID: 6779847; PMCID: PMC2010506.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    254. In vitro clonal assay for human metastatic melanoma cells. Stem Cells (1981). 1981; 1(1):61-72. Meyskens FL, Soehnlen BJ, Saxe DF, Casey WJ, Salmon SE. PMID: 7348870.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    255. Chemotherapy of ovarian cancer directed by the human tumor stem cell assay. Cancer Chemother Pharmacol. 1981; 6(3):279-85. Alberts DS, Chen HS, Salmon SE, Surwit EA, Young L, Moon TE, Meyskens FL. PMID: 6172215.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    256. The human thymus. I. Partial characterization of nonlymphoid cells. Thymus. 1980 Dec; 2(3):147-63. Jones JF, Meyskens FL, Nagle RB. PMID: 6258273.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    257. Biological and biochemical properties of a human uveal melanocyte-derived cell line. In Vitro. 1980 Sep; 16(9):775-80. Meyskens FL, Berglund EB, Saxe DF, Fuller BB, Pacelli LZ, Hall JD, Ray CG. PMID: 6773878.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    258. Characterization of the effects of different retinoids on the growth and differentiation of a human melanoma cell line and selected subclones. Cancer Res. 1980 Jul; 40(7):2194-6. Meyskens FL, Fuller BB. PMID: 6770995.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    259. Terminal deoxynucleotidyl transferase development in the postnatal human thymus. Pediatr Res. 1980 May; 14(5):780-1. Meyskens FL, Jones JF, Kiefer CA. PMID: 6966786.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    260. Human melanoma colony formation in soft agar. Prog Clin Biol Res. 1980; 48:85-99. Meyskens FL. PMID: 7208529.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    261. Tamoxifen in metastatic malignant melanoma. Cancer Treat Rep. 1980 Jan; 64(1):171-3. Meyskens FL, Voakes JB. PMID: 7379053.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    262. Clinical correlations of in vitro drug sensitivity. Prog Clin Biol Res. 1980; 48:223-45. Salmon SE, Alberts DS, Meyskens FL, Durie BG, Jones SE, Soehnlen B, Young L, Chen HS, Moon TE. PMID: 7193872.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    263. Inhibition of human melanoma colony formation by retinoids. Cancer Res. 1979 Oct; 39(10):4055-7. Meyskens FL, Salmon SE. PMID: 476643.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    264. Separation of normal human bone marrow cells by counterflow centrifugal elutriation. I. Morphological analysis and subfractionation of neutrophilic granulocytes. Exp Hematol. 1979 Sep; 7(8):401-10. Meyskens FL, Kiefer CA, Holmes DK, Gerner EW. PMID: 510435.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    265. Terminal transferase: its evolving role. N Engl J Med. 1978 Apr 13; 298(15):845-6. Meyskens FL, Jones SE. PMID: 273144.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    266. RNA tumor viruses and human leukemia. Compr Ther. 1978 Feb; 4(2):42-8. Gallo RC, Meyskens FL. PMID: 624212.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    267. Male breast cancer: a review. Cancer Treat Rev. 1976 Jun; 3(2):83-93. Meyskens FL, Tormey DC, Neifeld JP. PMID: 782703.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    Frank's Networks
    Concepts (809)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (27)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCI Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California